Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01811862 · ClinicalTrials.gov registry record · NA
Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT01811862: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01811862 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01811862, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
This is a prospective randomized controlled trial to obtain preliminary data for the design of a future definitive efficacy study. A randomized controlled trial is needed because comparison to historical data would be biased. The investigators will use sham acupuncture as the control to account for effect from attention from and interaction with the therapist.
Interventions
- PROCEDURE Acupuncture
- PROCEDURE Sham acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2013-03 |
| Est. Completion | 2021-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01811862
The ClinicalTrials.gov registry entry for NCT01811862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acupuncture is the first listed.
NCT01811862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01811862 about?
NCT01811862 is a clinical study titled "Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients". This is a prospective randomized controlled trial to obtain preliminary data for the design of a future definitive efficacy study. A randomized controlled trial is needed because comparison to historical data would be biased. The investigators will use sham acupuncture as the control to account for ...
What is the current status of trial NCT01811862?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2013-03. Estimated completion is 2021-12-10.
What interventions are being tested in trial NCT01811862?
The interventions under investigation include: Acupuncture (PROCEDURE), Sham acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT01811862?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.